Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 11 - 09 entities : Inovio pharmaceuticals, inc. save search
INOVIO Reports Third Quarter 2021 Financial Results
Published: 2021-11-09 (Crawled : 22:00) - inovio.com
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: -0.54%
H: 0.0%
C: -0.01%
SNY | News | $45.56 -1.19% 910K
|
Health Technology
|
| O: 0.66%
H: 0.25%
C: -0.89%
INO 2 d | $10.54 -4.79% 180K
|
Health Technology
|
| O: 0.86%
H: 6.18%
C: 0.13%
financial results results
INOVIO Receives U.S. FDA Authorization to Proceed with INNOVATE Phase 3 Segment for its COVID-19 Vaccine Candidate, INO-4800, in the U.S.
Published: 2021-11-09 (Crawled : 13:15) - inovio.com
INO 2 d | $10.54 -4.79% 180K
|
Health Technology
|
| O: 4.79%
H: 7.71%
C: 0.71%
covid fda vaccine phase 3 ino-4800
Gainers vs Losers
| 83% | 17% |
Top 10 Gainers
AGBA | $0.7995 99.88% 73M
|
Finance
BPTH | $6.21 91.67% 58M
|
Health Technology
INVO | $1.36 78.95% 3.6M
|
Health Technology
TIRX | $0.8258 70.34% 50M
|
ISPC | $0.307 44.13% 3.6M
|
Professional, Scientific, and T...
SINT | $0.0504 35.12% 300M
|
Health Technology
VTNR S | $1.295 32.25% 5.5M
|
Industrial Services
ALRN | $5.53 30.12% 250K
|
Health Technology
SMSI 4 | $2.53 29.74% 510K
|
Technology Services
HOLO | $2.86 27.68% 28M
|
Your saved searches
Save your searches and get alerts when important news are released.